KRN7000 applied to lymphoma research

NKT Cell Responses to B Cell Lymphoma

NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B cell lymphoma
















New 7DW8-5 glycolipid


Now available 7DW8-5 glycolipid derivative of Alpha-GalCer for human and mice iNKT immunoresearch


Meet Funakoshi Company
at the following meetings:

NIH Research Festival
Bethesda, MD
September 13-14, 2018

San Diego, CA
December 8-12